gene expression
Wren Labs Launches Neuroendocrine Tumor Liquid Biopsy in Asia, Works on Expanding Testing Menu
Premium
The Branford, Connecticut-based company is preparing to launch a prostate cancer liquid biopsy test while in early discussions to expand its existing test into Japan.
Duke Researchers Use Veracyte Data to ID Prostate Cancer Subgroups for Added Post-Surgery Treatment
Premium
The recent JCO Precision Oncology study could bolster the research use case for Veracyte's Decipher GRID database in better defining prostate cancer subgroups.
CMS Contractor Proposes Noncoverage of Castle Biosciences Skin Cancer Test
The contractor said that the test has not yet demonstrated definitive value above the combination of available clinical, pathological, and staging criteria in accurate risk stratification.
Pacific Edge Ramps up Clinical Utility Studies, Commercial Efforts Behind Bladder Cancer Test
Premium
The New Zealand-based diagnostics firm is hoping the coming year will be a tipping point toward new guideline inclusion and broader adoption.
Prominent players in the market cited maturing validity data and updated guidelines that have led to growing awareness among doctors and patients.